MB
Matthew Barcus Chardan Capital Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
uniQure
QURE
$985M
| $17.95 | $27 |
50%
upside
| Buy | 2 years ago |
|
2 |
2
Immunovant
IMVT
$2.99B
| $17.14 | $32 |
87%
upside
| Buy | 2 years ago |
|
3 |
3
Immunome
IMNM
$916M
| $10.52 | $8 |
24%
downside
| Buy | 2 years ago |
|